Circulating microRNAs as potential markers of human drug‐induced liver injury

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Hepatology

• Publication date

  2011-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/hep.24538PMID 22045675
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating microRNAs (miRNA) in serum of patients with prostate cancer.

  2011cited by this paper
• Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma

  2011cited by this paper
• Serum and urinary free microRNA level in patients with systemic lupus erythematosus

  2011cited by this paper
• Serum miR-122 as a Biomarker of Necroinflammation in Patients With Chronic Hepatitis C Virus Infection

  2011cited by this paper
• Assessment of candidate biomarkers of drug-induced hepatobiliary injury in preclinical toxicity studies.

  2010cited by this paper
• Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor.

  2010cited by this paper
• The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.

  2010cited by this paper
• A case of acetaminophen (paracetamol) causing renal failure without liver damage in a child and review of literature

  2010cited by this paper
• Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases.

  2010cited by this paper
• Circulating microRNAs, potential biomarkers for drug-induced liver injury

  2009cited by this paper
• Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties

  2009cited by this paper
• Detection of the mitochondrial and catalytically active alanine aminotransferase in human tissues and plasma.

  2009cited by this paper
• Blood Pressure-Independent Reduction in Proteinuria and Arterial Stiffness After Acute Endothelin-A Receptor Antagonism in Chronic Kidney Disease

  2009cited by this paper
• Integration of microRNA miR-122 in hepatic circadian gene expression.

  2009cited by this paper
• High-mobility group box-1 protein and keratin-18, circulating serum proteins informative of acetaminophen-induced necrosis and apoptosis in vivo.

  2009cited by this paper
• Circulating microRNAs as stable blood-based markers for cancer detection

  2008cited by this paper
• miR-122, a paradigm for the role of microRNAs in the liver.

  2008cited by this paper
• Characterization of microRNA expression profiles in normal human tissues

  2007cited by this paper
• BMC Genomics BioMed Central

  2007influential reference
• Isoforms of alanine aminotransferases in human tissues and serum--differential tissue expression using novel antibodies.

  2007cited by this paper
• Exertional Rhabdomyolysis during a 246-km continuous running race.

  2006cited by this paper
• Acetaminophen‐induced acute liver failure: Results of a United States multicenter, prospective study

  2005cited by this paper
• Intensified Cloning Efforts Have Revealed Numer

  2004cited by this paper
• Acetaminophen and the U.S. acute liver failure study group: Lowering the risks of hepatic failure

  2004cited by this paper
• miR-122, a Mammalian Liver-Specific microRNA, is Processed from hcr mRNA and MayDownregulate the High Affinity Cationic Amino Acid Transporter CAT-1

  2004cited by this paper
• Identification of tissue-specific microRNAs from mouse.

  2002cited by this paper
• Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States

  2002cited by this paper
• Serum enzyme activities in individuals with different levels of physical fitness.

  1993cited by this paper
• Clearance of argininosuccinate synthetase from the circulation in acute liver disease.

  1990cited by this paper

• Circulating Liver-Enriched miR-122 in COVID-19 Patients: A Longitudinal Real-Life Study

  2026cites this paper
• Special Issue “Mechanistic and Prognostic Biomarkers in Liver Diseases”

  2025cites this paper
• Limited Diagnostic Value of miRNAs in Early Trauma-Induced Liver Injury: Only miRNA-122 Emerges as a Late-Phase Marker

  2025cites this paper
• Perspectives and Tools in Liver Graft Assessment: A Transformative Era in Liver Transplantation

  2025cites this paper
• Establishing a miRNA panel for hepatocellular carcinoma screening through a multicenter study

  2025cites this paper
• CMTM7 inhibits TLR4 signaling pathway via promoting Rab5 activation and alleviates acute liver injury

  2025cites this paper
• Subclinical Hepatic Injury and Dysfunction Following Surgery: Evidence From a Young and Aged Laparotomy Murine Model

  2025cites this paper
• Differential miRNA signatures in Hepatitis E Virus Infection: Insights into acute, chronic, and pregnancy-related outcomes

  2025cites this paper
• Serum microRNA-181a Expression Level in Patients with Acute Liver Failure and Its Correlation with Prognosis

  2024cites this paper
• Development of a Modular miRNA-Responsive Biosensor for Organ-Specific Evaluation of Liver Injury

  2024cites this paper
• Profile of plasma microRNAs as a potential biomarker of Wilson’s disease

  2024cites this paper
• Establishing reference ranges for circulating biomarkers of drug‐induced liver injury in healthy human volunteers

  2024cites this paper
• Fluorescent probes for sensing peroxynitrite: biological applications

  2024cites this paper
• The Role of miR-155 and miR-122 in Valproic Acid-Induced Liver Injury

  2024cites this paper
• Semiarbitrary qPCR for Sensitive Detection of Circulating miRNA via Terminal Deoxynucleotidyl Transferase-Assisted RNA-Primed DNA Polymerization.

  2024cites this paper
• Artificial intelligence-based evaluation of prognosis in cirrhosis

  2024cites this paper
• Prenatal cigarette smoke exposure sensitizes acetaminophen-induced liver injury by modulating miR-34a-5p in male offspring mice

  2024cites this paper
• Evaluation of capillary miR-122 as a prognostic biomarker of paracetamol-induced liver toxicity

  2024cites this paper
• Micrornas in Anticancer Drugs Hepatotoxicity: From Pathogenic Mechanism and Early Diagnosis to Therapeutic Targeting by Natural Products.

  2024cites this paper
• Ultrasensitive upconverting nanoprobes for in situ imaging of drug-induced liver injury using miR-122 as the biomarker.

  2024cites this paper
• Multiplex Profiling of miR-122 for Preclinical and Clinical Evaluation of Drug-Induced Liver Injury by a Full-Scale Platform.

  2024cites this paper
• Plant-derived miR166a-3p packaged into exosomes to cross-kingdom inhibit mammary cell proliferation and promote apoptosis by targeting APLNR gene.

  2024cites this paper
• The Untapped Biomarker Potential of MicroRNAs for Health Risk–Benefit Analysis of Vaping vs. Smoking

  2024cites this paper
• Cytokeratin-18 is a sensitive biomarker of alanine transaminase increase in a placebo-controlled, randomized, crossover trial of therapeutic paracetamol dosing (PATH-BP biomarker substudy)

  2024cites this paper
• Multiplexed MicroRNA Biomarker Detection by Bridging Lifetime Filtering Imaging and Dynamic Chemistry Labeling

  2024cites this paper
• Amplification-free electrochemical biosensor detection of circulating microRNA to identify drug-induced liver injury.

  2023cites this paper
• Hepatocyte-derived extracellular vesicles miR-122-5p promotes hepatic ischemia reperfusion injury by regulating Kupffer cell polarization.

  2023cites this paper
• Roles and Application of Extracellular Vesicles Occurring Endogenously and Naturally

  2023cites this paper
• Expression Analysis of Exosomal MicroRNAs in Chlorpromazine Treated Human Hepatic Spheroids: A Promising Tool for Novel Drug-Induced Liver Injury Biomarker Discovery

  2023cites this paper
• MicroRNAs in high-grade gliomas: What is their role?

  2023cites this paper
• The Evolution of Circulating Biomarkers for Use in Acetaminophen/Paracetamol-Induced Liver Injury in Humans: A Scoping Review.

  2023cites this paper
• Alcoholic Setdb1 suppression promotes hepatosteatosis in mice by strengthening Plin2.

  2023cites this paper
• MiR-766-3p and miR-671-5p attenuate aristolochic acid-induced hepatotoxicity by directly targeting the key bioactivating enzyme NQO1.

  2023cites this paper
• Cascaded recycling amplification mediated in situ synthesis of silver nanoclusters for the construction of sensitive and label-free electrochemical sensor

  2023cites this paper
• Advances in the understanding of acetaminophen toxicity mechanisms: a clinical toxicology perspective

  2023cites this paper
• Salvianolic Acid A Protects against Acetaminophen-Induced Hepatotoxicity via Regulation of the miR-485-3p/SIRT1 Pathway

  2023cites this paper
• Evaluation of diagnostic and prognostic candidate biomarkers in drug‐induced liver injury vs. other forms of acute liver damage

  2023cites this paper
• Biomarkers of liver diseases

  2023cites this paper
• Acetaminophen treatment in children and adults with spinal muscular atrophy: a lower tolerance and higher risk of hepatotoxicity.

  2023cites this paper
• Analysis of serum microRNA‐122 in a randomized controlled trial of N‐acetylcysteine for treatment of antituberculosis drug‐induced liver injury

  2023cites this paper
• Mitochondrial miR-23b-5p is a new biomarker of warm ischaemic injury in donor livers and a candidate for graft evaluation: experimental studies

  2023cites this paper
• Chemokines in Primary Liver Cancer

  2022cites this paper
• Open a new window in the world of circulating microRNAs by merging ChemiRNA Tech with a Luminex platform

  2022cites this paper
• Spotlight on liver macrophages for halting liver disease progression and injury

  2022cites this paper
• Astaxanthin Attenuates the Changes in the Expression of MicroRNAs Involved in the Activation of Hepatic Stellate Cells

  2022cites this paper
• Micro RNAs as emerging therapeutic targets in liver diseases.

  2022cites this paper
• MicroRNAs: Small molecules with big impacts in liver injury

  2022influential citation
• A highly sensitive PNA‐microarray system for miRNA122 recognition

  2022cites this paper
• An Exceptional and Universal DNA Walker Amplified “One-to-Many” CRISPR/Cas12a-Mediated Fluorescent Biosensor for Ultrasensitive Detection of Non-DNA Biomarkers

  2022cites this paper
• Microfluidic system for near-patient extraction and detection of miR-122 microRNA biomarker for drug-induced liver injury diagnostics

  2022cites this paper
• Factors influencing circulating microRNAs as biomarkers for liver diseases

  2022cites this paper
• Potential deleterious effects of paracetamol dose regime used in Nigeria versus that of the United States of America

  2022cites this paper
• Proximity sensitive detection of microRNAs using electrochemical impedance spectroscopy biosensors.

  2022cites this paper
• Liver Damage and microRNAs: An Update

  2022cites this paper
• Effects of Desflurane exposure and Laparotomy on genomic biomarkers and hepatic histopathology in an experimentally induced liver injury model: A pilot study

  2022cites this paper
• Special Section on Drug Metabolism in Liver Injury and Repair — Minireview Novel Clinical Biomarkers for Drug-Induced Liver Injury S

  2022cites this paper
• Non-alcoholic fatty liver disease establishment and progression: genetics and epigenetics as relevant modulators of the pathology

  2022cites this paper
• Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD).

  2021cites this paper
• Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice

  2021cites this paper
• Bilirubin and Epigenetic Modifications in Metabolic and Immunometabolic Disorders.

  2021cites this paper
• Novel Clinical Biomarkers for Drug-Induced Liver Injury

  2021cites this paper
• Insight into microRNAs-Mediated Communication between Liver and Brain: A Possible Approach for Understanding Acute Liver Failure?

  2021cites this paper
• A Review of the Clinical and Therapeutic Implications of Neuropathic Pain

  2021cites this paper
• Potential of sperm small non-coding RNAs as biomarkers of testicular toxicity in a doxorubicin-induced mouse model

  2021cites this paper
• Identification of miR-199a-5p, miR-214-3p and miR-99b-5p as Fibrosis-Specific Extracellular Biomarkers and Promoters of HSC Activation

  2021cites this paper
• Systems analysis of miRNA biomarkers to inform drug safety

  2021cites this paper
• Clinical impact of serum exosomal microRNA in liver fibrosis

  2021cites this paper
• Role of microRNA-218-5p in sevoflurane-induced protective effects in hepatic ischemia/reperfusion injury mice by regulating GAB2/PI3K/AKT pathway

  2021cites this paper
• Circulating miR-122 in patients with non-toxic acute acetaminophen ingestions

  2021cites this paper
• A novel microRNA-based prognostic model outperforms standard prognostic models in patients with acetaminophen-induced acute liver failure.

  2021cites this paper
• Evaluating the Sensitivity and Specificity of Promising Circulating Biomarkers to Diagnose Liver Injury in Humans.

  2021cites this paper
• Methodological considerations for measuring biofluid-based microRNA biomarkers

  2021cites this paper
• A novel fluorescent probe for the detection of peroxynitrite and its application in acute liver injury model

  2021cites this paper
• Development of a nanotechnology-based approach for capturing and detecting nucleic acids by using flow cytometry

  2021cites this paper
• Global research trends of drug-induced liver injury (DILI) in the past two decades: a bibliometric and visualized study.

  2021cites this paper
• Recent progress in the use of microRNAs as biomarkers for drug-induced toxicities in contrast to traditional biomarkers: A comparative review.

  2021cites this paper
• Extracellular vesicles: Roles and applications in drug-induced liver injury.

  2021cites this paper
• The assessment of selected MiRNAs profile in HIV, HBV, HCV, HIV/HCV, HIV/HBV Co-infection and elite controllers for determination of biomarker.

  2020cites this paper
• Hepatic Adaptation to Therapeutic Doses of acetaminophen: An Exploratory Study in healthy Individuals.

  2020cites this paper
• Novel hepatotoxicity biomarkers of extracellular vesicle (EV)-associated miRNAs induced by CCl4

  2020cites this paper
• Drug Induced Liver Injury (DILI). Mechanisms and Medicinal Chemistry Avoidance/Mitigation Strategies.

  2020cites this paper
• Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities

  2020cites this paper
• Liquid biopsy in chronic liver disease.

  2020cites this paper
• Advances in biomarker development in acetaminophen toxicity.

  2020cites this paper
• Mechanism-based identification of plasma metabolites associated with liver toxicity.

  2020cites this paper
• Differential Associations of Circulating MicroRNAs With Pathogenic Factors in NAFLD

  2020cites this paper
• Circulating argonaute-bound microRNA-126 reports vascular dysfunction & response to treatment in acute & chronic kidney disease

  2020cites this paper
• Markers of liver regeneration—the role of growth factors and cytokines: a systematic review

  2020cites this paper
• miR-218 Expressed in Endothelial Progenitor Cells Contributes to the Development and Repair of the Kidney Microvasculature.

  2020cites this paper
• Pharmacokinetics and Pharmacodynamics of Ursodeoxycholic Acid in an Overweight Population With Abnormal Liver Function

  2020cites this paper
• Direct detection of miR-122 in hepatotoxicity using dynamic chemical labelling overcomes stability and isomiR challenges.

  2020cites this paper
• Plasma microRNAs as predictive biomarkers of liver fibrosis and cirrhosis in patients with HBV-associated disease

  2020cites this paper
• Transfer of hepatocellular microRNA regulates cytochrome P450 2E1 in renal tubular cells

  2020cites this paper
• Edinburgh Research Explorer Transfer of hepatocellular microRNA regulates cytochrome P450 2E1 in renal tubular cells

  2020cites this paper
• Drug-Induced Liver Injury (DILI): Current status and future directions for drug development and the post-market setting

  2020cites this paper
• A general model for cell death and biomarker release from injured tissues

  2020cites this paper
• Evaluation of miR-122 Serum Level and IFN-λ3 Genotypes in Patients with Chronic HCV and HCV-infected Liver Transplant Candidate.

  2020cites this paper
• Identification of miR-4793-3p as a potential biomarker for bacterial infection in patients with hepatitis B virus-related liver cirrhosis: A pilot study

  2020cites this paper
• Exosomal miRNAs as Potential Biomarkers to Monitor Phosphodiesterase 5 Inhibitor Induced Anti-Fibrotic Effects on CCl4 Treated Rats

  2020cites this paper
• Biomarkers of drug-induced liver injury: a mechanistic perspective through acetaminophen hepatotoxicity

  2020cites this paper